"10.1371_journal.pone.0125499","plos one","2015-05-08T00:00:00Z","Åsa Nääv; Lena Erlandsson; Josefin Axelsson; Irene Larsson; Martin Johansson; Lena Wester-Rosenlöf; Matthias Mörgelin; Vera Casslén; Magnus Gram; Bo Åkerström; Stefan R Hansson","Obstetrics and Gynecology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Nephrology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Clinical Pathology, Department of Laboratory Medicine, Lund University, Malmö, Sweden; Infection Medicine, Department of Clinical Sciences Lund, Lund University, Lund, Sweden","Conceived and designed the experiments: ÅN LE SH BÅ MG IL LWR JA. Performed the experiments: ÅN LE IL LWR VC JA. Analyzed the data: ÅN LE JA IL MJ MM. Contributed reagents/materials/analysis tools: VC LWR MG BÅ. Wrote the paper: ÅN LE SH. Revised the manuscript: ÅN LE JA IL MJ MM LWR VC MG BÅ SH. Final approval: ÅN LE JA IL MJ MM LWR VC MG BÅ SH.","The authors of this manuscript have read the journals policy and have the following competing interests: Stefan R Hansson, Bo Åkerström and Magnus Gram hold patents for the diagnosis and treatment of preeclampsia. They are also co-founders of the companies Preelumina Diagnostics AB and A1M Pharma AB (www.a1m.se). The following patents have been filed: 1) A new diagnostic marker and treatment for preeclampsia. First filed January 2007 and PCT filed February 2008 (PCT/EP2008001051) by Bo Åkerström and Stefan Hansson. 2) HbF and A1M as early stage markers for preeclampsia. Appl. No 100323 P14074, filing date March 2010 by Stefan Hansson, Magnus G Olsson and Bo Åkerström. 3) Medical use of the radical scavenger and antioxidantn alpha 1-microglobulin. First filed July 2008 and PCT filed July 2009 (PCT/EP2009/005217-E3-11) by Bo Åkerström, Stefan Hansson, Magnus G Olsson and Martin Olsson. The authors hereby confirm that nothing they have declared alters their adherence to all PLOS ONE policies on sharing data and materials.","2015","05","Åsa Nääv","ÅN",11,TRUE,8,6,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
